Please sign in to follow a disease.
Could a lifesaving leukemia drug harm Men's sexual health?
NCT ID NCT07061145
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study looks at whether tyrosine kinase inhibitors (TKIs), the standard treatment for chronic myeloid leukemia (CML), might be linked to erectile dysfunction (ED) in men. Researchers will track 350 male patients who started TKI therapy, using questionnaires and medical records to see how many develop ED and whether the type of TKI matters. The goal is to better understand the long-term side effects of these drugs and potentially improve patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, nilotinib, bosutinib, or ponatinib, given as standard care for chronic myeloid leukemia.
- What this could lead to
- If a link is confirmed, it could lead to better monitoring and management of erectile dysfunction in men taking TKIs, improving quality of life and potentially aiding early detection of cardiovascular risk.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The results may be influenced by other factors, and the findings might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda USL IRCCS di Reggio Emilia
RECRUITINGReggio Emilia, RE, 42121, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- New urethral gel could help men with erectile dysfunction
- Ancient wisdom meets modern medicine: new study maps ED patterns
- New study aims to help cancer survivors manage other health problems
- New combo shows promise for Hard-to-Treat lung cancer
- Liver cancer patients: do pre-transplant drugs improve outcomes?